Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep

• ClinicalTrials.gov Identifier: NCT00127686
• Recruitment Status: Completed
• First Posted: August 8, 2005
• Last Update Posted: November 24, 2017
• Sponsor: Penn State University
• Collaborator: National Honey Board
• Information provided by (Responsible Party): Penn State University

Study Description

Brief Summary:

Cough is the most common reason for an acute care doctor's visit in the United States. Cough can affect sleep for both coughing children and their parents. The American Academy of Pediatrics does not endorse the use of dextromethorphan (DM), the most common over-the-counter (OTC) cough medication because of a lack of efficacy data and some potential for toxicity, particularly when taken in excess. In fact, DM has previously been shown to be no better than a placebo for cough in children. Therefore, alternative, therapeutic agents are needed. Honey anecdotally provides relief for symptoms due to upper respiratory tract infection (URI). This study seeks to use a survey to evaluate whether a single dose of honey and/or DM is better than no treatment at all for controlling nocturnal cough in children with URI and the effect of the treatments on sleep quality for coughing children and their parents. A single dose of honey or DM will be superior to no treatment for control of nocturnal cough due to upper URI as rated by both parents and children and will improve the sleep quality for those children and parents. Compared to DM, honey will be superior for controlling nocturnal cough due to upper URI (also based on child and parental report).

Condition or disease	Intervention/treatment	Phase
Cough; Respiratory Tract Infections	Drug: Dextromethorphan; Drug: Buckwheat Honey	Phase 1

Detailed Description:

Cough is one of the most common reasons for a doctor's visit in the United States and may be the most bothersome symptom for children with colds. It is particularly annoying at night because it can interrupt sleep for both coughing children and their parents. Dextromethorphan (DM), the most common over-the-counter (OTC) "cough medication," may not be as helpful for these symptoms as previously believed. Because of this, treatments are needed to better reduce the symptoms from a cold. Honey is a naturally occurring substance that may provide relief for cold symptoms. Children are being offered the opportunity to take part in this research because they have been diagnosed with a cold and have had difficulty sleeping due to their cough.

The purpose of this research is to use a survey to see if a single dose of honey or DM is better than no treatment at all for controlling nighttime cough in children, ages 2 to less than 18 years with a cold and if the medicine or honey helps the quality of sleep for the coughing children and their parents. DM has been approved by the Food and Drug Administration (FDA) and is available over the counter. The form of honey used in this study may also be purchased without a doctor's prescription.

About 125 male and female children from 2 to less than 18 years old will take part in this study at the Hershey Medical Center.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 105 participants
• Allocation: Randomized
• Intervention Model: Factorial Assignment
• Masking: Double
• Primary Purpose: Treatment
• Official Title: Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
• Study Start Date: September 2005
• Actual Primary Completion Date: December 2006
• Actual Study Completion Date: December 2006

Arms and Interventions

Outcome Measures

Primary Outcome Measures :

1. Compared with no treatment, honey and DM will: improve the sleep quality for children with cough due to URI and improve the sleep quality for the parents of children with cough due to URI [ Time Frame: 1 year ]

Eligibility Criteria

• Ages Eligible for Study: 2 Years to 18 Years (Child, Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• Ages 2 to <18 years
• Cough due to upper respiratory tract infection (URI), as determined by physical examination
• Sleep difficulty on the preceding night attributed to frequent cough
• Ability to swallow liquids
• Willingness of the child's guardian to participate in a survey

Exclusion Criteria:

• Signs/symptoms of more serious/treatable disease
• Itchy, watery eyes
• Frequent sneezing, tachypnea (respiratory rate >95th percentile) or labored breathing; symptoms for 8 or more days.
• History of asthma in the past 2 years
• Chronic lung disease, or seizure disorder
• Allergic reaction to honey or DM
• Selective serotonin reuptake inhibitors (SSRIs) or anti-malarial drugs
• Diabetes mellitus or signs/symptoms of insulin resistance

Contacts and Locations

Locations

United States, Pennsylvania

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States, 17545

Sponsors and Collaborators

Penn State University

National Honey Board

Investigators

• Principal Investigator: Ian M Paul, MD, MSc; Penn State College of Medicine

More Information

Additional Information:

Pediatric Clinical Research Office: Penn State Milton S. Hershey Medical Center 

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L, Berlin CM Jr. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med. 2007 Dec;161(12):1140-6. doi: 10.1001/archpedi.161.12.1140.

• Responsible Party: Penn State University
• ClinicalTrials.gov Identifier: NCT00127686
• Other Study ID Numbers: 21163
• First Posted: August 8, 2005
• Last Update Posted: November 24, 2017
• Last Verified: November 2017

Keywords provided by Penn State University:

cough; nocturnal cough; upper respiratory tract infection; sleep quality; childhood cough; Dextromethorphan; Honey

Additional relevant MeSH terms:

Respiratory Tract Infections; Cough; Infections; Respiration Disorders; Respiratory Tract Diseases; Signs and Symptoms, Respiratory; Dextromethorphan; Antitussive Agents; Respiratory System Agents; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Agents; Neurotransmitter Agents; Molecular Mechanisms of Pharmacological Action; Physiological Effects of Drugs